Halozyme Therapeutics
HALO
#2407
Rank
C$10.40 B
Marketcap
C$87.81
Share price
-2.19%
Change (1 day)
3.91%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): C$0.65 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are C$1.39 Billion. a decrease over its 2024 earnings that were of C$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 C$0.64 B-16.2%
2024 C$0.77 B59.94%
2023 C$0.48 B39.94%
2022 C$0.34 B0.16%
2021 C$0.34 B92.2%
2020 C$0.17 B-278.96%
2019 -C$0.11 Billion-9.45%
2018 -C$0.12 Billion-229.51%
2017 C$85.75 M-160.48%
2016 -C$0.15 Billion216.03%
2015 -C$44.87 Million-52.86%
2014 -C$95.18 Million-18.09%
2013 -C$0.12 Billion55.88%
2012 -C$74.55 Million169.94%
2011 -C$27.62 Million-63.44%
2010 -C$75.53 Million-7.19%
2009 -C$81.38 Million15.91%
2008 -C$70.21 Million83.89%
2007 -C$38.18 Million78.1%
2006 -C$21.44 Million16%
2005 -C$18.48 Million45.24%
2004 -C$12.73 Million682.42%
2003 -C$1.63 Million1659.12%
2002 -C$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$46.70 B 7,086.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.18 B 2,083.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$35.81 B 5,411.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.71 B 1,549.11%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-C$0.71 Billion-208.17%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C$42.84 M-93.41%๐Ÿ‡บ๐Ÿ‡ธ USA